期刊文献+

唾液乳杆菌降解4-硝基喹啉-1-氧化物所需条件的研究 被引量:2

Effective degradation of 4-Nitroquinoline-1-Oxide by Lactobacillus salivarius
下载PDF
导出
摘要 4-硝基喹啉-1-氧化物(4-NQO)是一种基因毒素。广西巴马老人源唾液乳杆菌FDB89可降解4-NQO为无毒物质。将不同浓度的唾液乳杆菌FDB89菌悬液与4-NQO溶液(4-NQO终浓度为20mg/L)混合,反应一定时间后分别取样,用高效液相色谱法(HPLC)检测其中的4-NQO含量变化情况。唾液乳杆菌FBD89菌体浓度达到OD600=2.3(约2.1×1011cfu/mL)时,降解现象比较明显,并在菌体浓度约为1.4×1013cfu/mL时能检测到4-NQO的降解产物。研究结果表明,唾液乳杆菌FBD89具有降解4-NQO的能力,降解能力随菌体浓度升高而提高。 4-Nitroquinoline-l-Oxide (4-NQO) is one kind of genotoxins. Lactobacillus salivarius FDB89, screened from Guangxi Bama longevity feces, could degrade 4-NQO to nontoxic substance. Different concentrations of L. salivarius FDB89 were added in reaction solution with 4-NQO (20mg/L). Samples were detected by high performance liquid chromatography (HPLC). The results showed that L. salivarius FDB89 could not degrade 4-NQO when its OD600 was lower than 2.3(about 2.1 × 10^13cfu/ml). When the concentration was about 1.4× 10^13cfu/ml, the degradation reaction was obvious and several intermediate metabolites or degradation products were detected. The degradation ability of L. salivarius FDB89 against 4-NQO had positive correlation with its density.
出处 《中国酿造》 CAS 北大核心 2011年第7期67-69,共3页 China Brewing
基金 “十一五”国家科技支撑计划课题支持(2006BAD04A06)
关键词 唾液乳杆菌 4-硝基喹啉-N-氧化物 降解 反应条件 Lactobacillus salivarius 4-Nitroquinoline-1-Oxide degradation reaction condition
  • 相关文献

参考文献10

  • 1BOND T J, YOUNG K L, ANDRUS T T. Characteristics of growth inhibition of Lactobacillus casei by 4-nitroquinoline-n-oxide[J]. Appi Environ Microbiol, 1970, 20 (4) : 536-538.
  • 2PARVEZ S, MALIK K A, KANG S A, et al. Probiotics and their fer mented food products are beneficial for health [J]. J Appl Mierobiol, 2006, 100(6) : 1171-1185.
  • 3HIRAYAMA K, RAFTER J. The role of lactic acid bacteria in colon cancer prevention: mechanistic considerations[J]. Anton Leeuw Int ,1 G, 1999, 76: 391-394.
  • 4LIDBECK A, NORD C E, RAFTER J, et al. Effect of Lactobacillus acidophilus supplements on mutagen excretion in faeces and urine in humans[J]. Mierob Eeol Health Dis, 1992,5 (1) : 59-67.
  • 5MURCH S H. Toll of allergy reduced by probiotics[J]. Lancet, 2001,357 (9262) : 1057-1059.
  • 6ISOLAURI E. Dietary modification of atopic disease: Use of probiotics in the prevention of atopic dermatitis[J]. Curt Allergy Asthma Rep, 2004,4: 270-275.
  • 7王芳,姜鹭,刘爱萍,郭兴华,任发政.高效液相色谱法测定唾液乳杆菌脱基因毒性作用[J].分析化学,2008,36(6):740-744. 被引量:11
  • 8KNASMULLER S, STEINKELLNER H, HIRSCHL A M, et al. Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines[J]. Mutat Res, 2001,480.. 129-138.
  • 9POOL-ZOBLE B L, NEUDECKER C, DOMIZLAFF I, et al. Lactobacillus and Bifidobactenum-mediated antigenotoxicity in the colon of rots [J]. Nutr Cancer, 1996, 26 (3) : 365-380.
  • 10MOROTOMI M, MITAO M.In vitro binding of potent mutagenic pyrolysates to intestinal bacteria[J]. J Natl Caneer Inst, 1986, 77 (1): 195 -201.

二级参考文献13

  • 1谢跃生,潘桂湘,高秀梅,刘昌孝.高效液相色谱技术在代谢组学研究中的应用[J].分析化学,2006,34(11):1644-1648. 被引量:25
  • 2蒋菁莉,徐彦军,娄飞,任发政.反相高效液相色谱-电喷雾质谱法分析食源血管紧张素转换酶抑制肽[J].分析化学,2007,35(3):427-430. 被引量:9
  • 3Parvez S, Malik K A, KangS A, Kim H Y. J. Appl. Microbiol., 2006, 100:1171-1185.
  • 4Commanea D, Hughes R, Shoat C, Rowland I. Mutat. Res. Fund. Mol. , 2005, 591:276 -289.
  • 5Arima Y, Nishigori C, Takeuchi T, Oka S, Morimoto K, Utani A, Miyachi Y. Toxicol. Sci. , 2006, 91(2) : 382 -392.
  • 6Speelman J, Lund H, Culling A, Kittredge J S, Williams B J, Albrecht T. J. Gen. Virol. , 1983, 64:2511 -2515.
  • 7Sugimura T, Okabe K, Nagao M. Cancer Res. , 1966, 26, Part 1:1717-1721.
  • 8Mersh-Sundermann V, Kevekordes S, Mochayedi S. Mutat. Res. , 1991, 252:51 -60.
  • 9Mersh-Sundermann V, Schneider U, Klopman G, Rosenkranz H S. Mutag. , 1994 : 205 - 224.
  • 10Quillardet P, Hofnung M. Murat. Res. - Fund. Mol. , 1985, 147:65-78.

共引文献10

同被引文献26

  • 1徐鹏昀,樊雯,徐美玲,张金兰,李平兰.植物乳杆菌素L-1对冷却肉的防腐保鲜效果研究[J].食品科学,2009,30(2):264-267. 被引量:11
  • 2杨颖,陈卫,汤坚,张灏.健康与龋病口腔唾液中乳杆菌的发酵类群与表面性质[J].中国微生态学杂志,2005,17(5):344-345. 被引量:7
  • 3陈晓峰,王淼,覃彩凤.Lactobacillus salivarius的培养和产抑菌物质条件的研究[J].食品工业科技,2007,28(4):93-96. 被引量:5
  • 4Raftis E J, Salvetti E, Torriani S, et al. Genomic Diversity of Lactobacillus salivarius [ J ]. Applied and Environmental Microbi- ology ,2011,77 ( 3 ) :954-965.
  • 5R.E.布坎南,N.E.吉木斯.洪俊华,译.伯杰细菌鉴定手册[M].北京:科学出版社,1974.
  • 6Mayanagi G, Kimura M, Nakaya S, et al. Probi0tic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria:a double-blinded, placebo- controlled, randomized clinical trial[ J 1. Journal of Clinical Pe- riodontology,2009,36(6) : 506-513.
  • 7Perez-cano F J, Honglin D, Yaqood P. In vitro immunomodula- tory activity of Lactobacillusferrnentum CECT5716 and Lactoba- cillus salivarius CECT5713 : two probiotic strains isolated from human breast milk [ J ]. Immunobiology, 2010,215 ( 12 ) : 996- 1004.
  • 8Langa S, Juan M R, Ruth I C, et al. Characterization of Lacto- bacillus salivarius CECT 5713, a strain isolated from human milk:from genotype to phenotype[ J]. Applied Microbiology and Biotechnology ,2012, 94 ( 5 ) : 1279-1287.
  • 9Arribas B, Garrido-mesa N, Peran L, et al. The immunomodu- latory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine [ J ]. European Journal of Clinical Nutrition,2012,51 (3) :365-374.
  • 10Zhang J H, Deng J, Wang Z S, et al. Modulatory Effects of Lactobacillus salivarius on Intestinal Mueosal Immunity of Piglets E J J. Current Microbiology,2011,62 (5) : 1623-1631.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部